Jon Cohen

@sciencecohen

Science magazine reporter. Most interested in infectious diseases, immunology, vaccines, public health, genomics, CRISPR, primates, surfing.

Cardiff, California
Vrijeme pridruživanja: travanj 2009.

Tweetovi

Blokirali ste korisnika/cu @sciencecohen

Jeste li sigurni da želite vidjeti te tweetove? Time nećete deblokirati korisnika/cu @sciencecohen

  1. proslijedio/la je Tweet
    prije 13 sati

    This suggests that the ICTV will announce a formal name for 2019-nCoV shortly.

    Poništi
  2. prije 18 sati

    Frank was a pioneering HIV/AIDS researcher in Kenya and trained loads of others there and in Canada. He'll be sorely missed.

    Poništi
  3. prije 22 sata
    Poništi
  4. prije 22 sata

    The cluster of cases linked to the market plus the positive environmental samples from it point to it as a source. To borrow from Dylan, you don't need a weatherman to know which way the wind blows. As for p-values, I don't even know how you assign one to the thesis.

    Poništi
  5. 4. velj
    Tweet je nedostupan.
    Poništi
  6. 4. velj

    I did not write that there was no link to that seafood market. I noted that there were earlier cases, which questioned whether the seafood market was the origin. Clearly, there are strong links to that market, as my story makes clear.

    Tweet je nedostupan.
    Poništi
  7. 3. velj

    Critical question: Do asymptomatic people spread the novel coronavirus? That alters containment efforts. A NEJM paper that answered "yes" now is backpedalling, as reports.

    Poništi
  8. 3. velj

    Thanks for the shoutout. Great list of important stories and studies.

    Poništi
  9. 3. velj

    Woe-begotten HIV vaccine field has more woe: The most advanced trial in humans, in 5400 South Africans, stopped early because of futility (read: doesn't work).

    Poništi
  10. 2. velj

    Many articles are in front of the paywall. You can also register for access () or of course subscribe.

    Poništi
  11. 1. velj

    Science has a landing page for all of our coronavirus outbreak coverage.

    Poništi
  12. 1. velj

    Today's WHO situation report: "In France, for the first time outside China, a healthcare worker was diagnosed as being ill with 2019-nCoV acute respiratory disease. The health worker treated two patients who were later identified as probable cases. "

    Poništi
  13. 1. velj

    From the paper you cite: "However, the induced antibody from these mice had weaker cross-reaction with the SARS-CoV S protein, and did not neutralize HIV pseudotyped with SARS-CoV S protein."

    Poništi
  14. proslijedio/la je Tweet
    1. velj

    Several unfounded claims emerging around sequences - worth following researchers like for thoughtful, balanced analysis of what is (and isn’t) happening

    Poništi
  15. 1. velj
    Poništi
  16. proslijedio/la je Tweet
    1. velj
    Odgovor korisnicima i sljedećem broju korisnika:

    Basically this true for many respiratory viruses, and no data (at least in the article) support this information specifically for . At this early time point in the epidemic, not possible to assess antibody longevity in my opinion

    Poništi
  17. 1. velj

    I suggest you read the comments on bioRxiv. They're roundly--and harshly--dismissive of the paper.

    Poništi
  18. 1. velj

    Thanks Carlos. Much appreciate the clap on the back.

    Poništi
  19. 1. velj

    Many thanks for your help in attempting to explain a complex topic.

    Poništi
  20. 1. velj
    Poništi

Čini se da učitavanje traje već neko vrijeme.

Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.

    Možda bi vam se svidjelo i ovo:

    ·